MXPA99010758A - Keratin fibre oxidation dyeing composition and dyeing method using same - Google Patents
Keratin fibre oxidation dyeing composition and dyeing method using sameInfo
- Publication number
- MXPA99010758A MXPA99010758A MXPA/A/1999/010758A MX9910758A MXPA99010758A MX PA99010758 A MXPA99010758 A MX PA99010758A MX 9910758 A MX9910758 A MX 9910758A MX PA99010758 A MXPA99010758 A MX PA99010758A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- composition according
- pyrazolo
- amino
- methyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 130
- 238000004043 dyeing Methods 0.000 title claims abstract description 37
- 230000003647 oxidation Effects 0.000 title claims abstract description 36
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 36
- 239000000835 fiber Substances 0.000 title claims abstract description 31
- 102000011782 Keratins Human genes 0.000 title claims abstract description 27
- 108010076876 Keratins Proteins 0.000 title claims abstract description 27
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 33
- 210000004209 Hair Anatomy 0.000 claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 claims abstract description 20
- 108090000790 Enzymes Proteins 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims description 48
- 239000011780 sodium chloride Substances 0.000 claims description 48
- 239000002253 acid Substances 0.000 claims description 43
- 150000001875 compounds Chemical class 0.000 claims description 23
- BOKGTLAJQHTOKE-UHFFFAOYSA-N 1,5-Dihydroxynaphthalene Chemical compound C1=CC=C2C(O)=CC=CC2=C1O BOKGTLAJQHTOKE-UHFFFAOYSA-N 0.000 claims description 21
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 19
- 229940088598 Enzyme Drugs 0.000 claims description 15
- 108090000854 Oxidoreductases Proteins 0.000 claims description 13
- 102000004316 Oxidoreductases Human genes 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl radical Chemical group [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 9
- 108010092464 Urate Oxidase Proteins 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical class N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 claims description 6
- YRLORWPBJZEGBX-UHFFFAOYSA-N 3,4-dihydro-2H-1,4-benzoxazine Chemical class C1=CC=C2NCCOC2=C1 YRLORWPBJZEGBX-UHFFFAOYSA-N 0.000 claims description 6
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N Amino radical Chemical group [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims description 6
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical class N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 claims description 6
- 229940058303 antinematodal Benzimidazole derivatives Drugs 0.000 claims description 6
- 150000001556 benzimidazoles Chemical class 0.000 claims description 6
- 150000002391 heterocyclic compounds Chemical class 0.000 claims description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 6
- 150000002475 indoles Chemical class 0.000 claims description 6
- -1 monocyclic pyridine compounds Chemical class 0.000 claims description 6
- NLMQHXUGJIAKTH-UHFFFAOYSA-N 4-hydroxyindole Chemical compound OC1=CC=CC2=C1C=CN2 NLMQHXUGJIAKTH-UHFFFAOYSA-N 0.000 claims description 5
- 229940054051 antipsychotic Indole derivatives Drugs 0.000 claims description 5
- 150000003217 pyrazoles Chemical class 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- LHGQFZQWSOXLEW-UHFFFAOYSA-N 1H-pyrazole-4,5-diamine Chemical compound NC=1C=NNC=1N LHGQFZQWSOXLEW-UHFFFAOYSA-N 0.000 claims description 4
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical compound C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 claims description 4
- 229940083082 Pyrimidine derivatives acting on arteriolar smooth muscle Drugs 0.000 claims description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Trioxopurine Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 4
- 229940116269 Uric Acid Drugs 0.000 claims description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 4
- 150000002476 indolines Chemical class 0.000 claims description 4
- DNTVKOMHCDKATN-UHFFFAOYSA-N pyrazolidine-3,5-dione Chemical class O=C1CC(=O)NN1 DNTVKOMHCDKATN-UHFFFAOYSA-N 0.000 claims description 4
- 150000003230 pyrimidines Chemical class 0.000 claims description 4
- YRBRVMGXTWJLBZ-UHFFFAOYSA-N 1H-imidazole;1H-pyrrole Chemical class C=1C=CNC=1.C1=CNC=N1 YRBRVMGXTWJLBZ-UHFFFAOYSA-N 0.000 claims description 3
- QRMLLECAADTTHG-UHFFFAOYSA-N 2H-pyrrolo[3,2-d][1,3]oxazole Chemical class C1=CC2=NCOC2=N1 QRMLLECAADTTHG-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- PNFZIEOWPDFJBH-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine-3,7-diamine Chemical compound NC1=CC=NC2=C(N)C=NN21 PNFZIEOWPDFJBH-UHFFFAOYSA-N 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- RQKQKYICHBSFNX-UHFFFAOYSA-N (4,5-diamino-1-ethylpyrazol-3-yl)methanol Chemical compound CCN1N=C(CO)C(N)=C1N RQKQKYICHBSFNX-UHFFFAOYSA-N 0.000 claims description 2
- LHGUPKWTLOUVPW-UHFFFAOYSA-N (4,5-diamino-1-methylpyrazol-3-yl)methanol Chemical compound CN1N=C(CO)C(N)=C1N LHGUPKWTLOUVPW-UHFFFAOYSA-N 0.000 claims description 2
- DPTWQNJCRFZYPL-UHFFFAOYSA-N (4,5-diamino-1-propan-2-ylpyrazol-3-yl)methanol Chemical compound CC(C)N1N=C(CO)C(N)=C1N DPTWQNJCRFZYPL-UHFFFAOYSA-N 0.000 claims description 2
- UPSQXZSGCSPEHA-UHFFFAOYSA-N 1-(2-hydroxypropyl)indol-4-ol Chemical compound C1=CC=C2N(CC(O)C)C=CC2=C1O UPSQXZSGCSPEHA-UHFFFAOYSA-N 0.000 claims description 2
- ZTENTJNRKHDCMC-UHFFFAOYSA-N 1-methylbenzimidazole-4,7-diol Chemical compound C1=CC(O)=C2N(C)C=NC2=C1O ZTENTJNRKHDCMC-UHFFFAOYSA-N 0.000 claims description 2
- HISBLXCPAMBVLZ-UHFFFAOYSA-N 1-methylbenzimidazole-5,6-diol Chemical compound OC1=C(O)C=C2N(C)C=NC2=C1 HISBLXCPAMBVLZ-UHFFFAOYSA-N 0.000 claims description 2
- WSMJTXVQAZYLAV-UHFFFAOYSA-N 1-methylindol-4-ol Chemical compound C1=CC=C2N(C)C=CC2=C1O WSMJTXVQAZYLAV-UHFFFAOYSA-N 0.000 claims description 2
- OOOVRUXKQGYTPJ-UHFFFAOYSA-N 1-methylindol-6-ol Chemical compound C1=C(O)C=C2N(C)C=CC2=C1 OOOVRUXKQGYTPJ-UHFFFAOYSA-N 0.000 claims description 2
- NZJKEQFPRPAEPO-UHFFFAOYSA-N 1H-benzimidazol-4-amine Chemical compound NC1=CC=CC2=C1N=CN2 NZJKEQFPRPAEPO-UHFFFAOYSA-N 0.000 claims description 2
- DODRSIDSXPMYQJ-UHFFFAOYSA-N 1H-benzimidazol-4-ol Chemical compound OC1=CC=CC2=C1N=CN2 DODRSIDSXPMYQJ-UHFFFAOYSA-N 0.000 claims description 2
- LCYKFWZACWTNDC-UHFFFAOYSA-N 1H-benzimidazole-4,7-diol Chemical compound OC1=CC=C(O)C2=C1N=CN2 LCYKFWZACWTNDC-UHFFFAOYSA-N 0.000 claims description 2
- YBMUVGQKRPSJLS-UHFFFAOYSA-N 1H-benzimidazole-5,6-diol Chemical compound C1=C(O)C(O)=CC2=C1NC=N2 YBMUVGQKRPSJLS-UHFFFAOYSA-N 0.000 claims description 2
- LUNUNJFSHKSXGQ-UHFFFAOYSA-N 1H-indol-4-amine Chemical compound NC1=CC=CC2=C1C=CN2 LUNUNJFSHKSXGQ-UHFFFAOYSA-N 0.000 claims description 2
- XAWPKHNOFIWWNZ-UHFFFAOYSA-N 1H-indol-6-ol Chemical compound OC1=CC=C2C=CNC2=C1 XAWPKHNOFIWWNZ-UHFFFAOYSA-N 0.000 claims description 2
- WTFWZOSMUGZKNZ-UHFFFAOYSA-N 1H-indol-7-amine Chemical compound NC1=CC=CC2=C1NC=C2 WTFWZOSMUGZKNZ-UHFFFAOYSA-N 0.000 claims description 2
- ORVPXPKEZLTMNW-UHFFFAOYSA-N 1H-indol-7-ol Chemical compound OC1=CC=CC2=C1NC=C2 ORVPXPKEZLTMNW-UHFFFAOYSA-N 0.000 claims description 2
- OWWAUBQOFLVUMS-UHFFFAOYSA-N 2,3-dihydro-1H-indol-4-ol Chemical compound OC1=CC=CC2=C1CCN2 OWWAUBQOFLVUMS-UHFFFAOYSA-N 0.000 claims description 2
- UMXPKGQJQAQXLU-UHFFFAOYSA-N 2,3-dihydro-1H-indol-6-amine Chemical compound NC1=CC=C2CCNC2=C1 UMXPKGQJQAQXLU-UHFFFAOYSA-N 0.000 claims description 2
- JWLQULBRUJIEHY-UHFFFAOYSA-N 2,3-dihydro-1H-indol-6-ol Chemical compound OC1=CC=C2CCNC2=C1 JWLQULBRUJIEHY-UHFFFAOYSA-N 0.000 claims description 2
- SYEYEGBZVSWYPK-UHFFFAOYSA-N 2,5,6-triamino-1H-pyrimidin-4-one Chemical compound NC1=NC(N)=C(N)C(O)=N1 SYEYEGBZVSWYPK-UHFFFAOYSA-N 0.000 claims description 2
- HARBPHQCTIDSBX-UHFFFAOYSA-N 2-[(7-aminopyrazolo[1,5-a]pyrimidin-3-yl)amino]ethanol Chemical compound NC1=CC=NC2=C(NCCO)C=NN12 HARBPHQCTIDSBX-UHFFFAOYSA-N 0.000 claims description 2
- AJZRIOLJTXDFDY-UHFFFAOYSA-N 2-benzyl-5-methylpyrazole-3,4-diamine Chemical compound NC1=C(N)C(C)=NN1CC1=CC=CC=C1 AJZRIOLJTXDFDY-UHFFFAOYSA-N 0.000 claims description 2
- URPJUMVYJFHGOR-UHFFFAOYSA-N 2-benzylpyrazole-3,4-diamine Chemical compound NC1=C(N)C=NN1CC1=CC=CC=C1 URPJUMVYJFHGOR-UHFFFAOYSA-N 0.000 claims description 2
- MEKRUGGNBTYVRV-UHFFFAOYSA-N 2-ethyl-5-methylpyrazole-3,4-diamine Chemical compound CCN1N=C(C)C(N)=C1N MEKRUGGNBTYVRV-UHFFFAOYSA-N 0.000 claims description 2
- USVXDODAPOBXCF-UHFFFAOYSA-N 2-methyl-1H-benzimidazol-4-amine Chemical compound C1=CC=C2NC(C)=NC2=C1N USVXDODAPOBXCF-UHFFFAOYSA-N 0.000 claims description 2
- HLPAESMITTURFN-UHFFFAOYSA-N 2-methyl-1H-benzimidazol-4-ol Chemical compound C1=CC=C2NC(C)=NC2=C1O HLPAESMITTURFN-UHFFFAOYSA-N 0.000 claims description 2
- AXUDYYPUJZTLSH-UHFFFAOYSA-N 2-methyl-1H-benzimidazole-5,6-diol Chemical compound OC1=C(O)C=C2NC(C)=NC2=C1 AXUDYYPUJZTLSH-UHFFFAOYSA-N 0.000 claims description 2
- XBVSGEGNQZAQPM-UHFFFAOYSA-N 2-methyl-1H-indol-4-ol Chemical compound C1=CC=C2NC(C)=CC2=C1O XBVSGEGNQZAQPM-UHFFFAOYSA-N 0.000 claims description 2
- XOAXOKSJNVLLHZ-UHFFFAOYSA-N 2-methylpyrazole-3,4-diamine Chemical compound CN1N=CC(N)=C1N XOAXOKSJNVLLHZ-UHFFFAOYSA-N 0.000 claims description 2
- CTGVWWNOCSCKKI-UHFFFAOYSA-N 2-tert-butyl-5-methylpyrazole-3,4-diamine Chemical compound CC1=NN(C(C)(C)C)C(N)=C1N CTGVWWNOCSCKKI-UHFFFAOYSA-N 0.000 claims description 2
- UVUGDGRIYQQKIT-UHFFFAOYSA-N 3,4-dihydro-2H-1,4-benzoxazin-6-amine Chemical compound O1CCNC2=CC(N)=CC=C21 UVUGDGRIYQQKIT-UHFFFAOYSA-N 0.000 claims description 2
- HWWIVWKTKZAORO-UHFFFAOYSA-N 3,4-dihydro-2H-1,4-benzoxazin-6-ol Chemical compound O1CCNC2=CC(O)=CC=C21 HWWIVWKTKZAORO-UHFFFAOYSA-N 0.000 claims description 2
- FBPSBGSWWFBXQB-UHFFFAOYSA-N 4,7-dimethoxy-1H-benzimidazole Chemical compound COC1=CC=C(OC)C2=C1N=CN2 FBPSBGSWWFBXQB-UHFFFAOYSA-N 0.000 claims description 2
- BTWUUHKQHOSMIN-UHFFFAOYSA-N 5,6-dimethoxy-1H-benzimidazole Chemical compound C1=C(OC)C(OC)=CC2=C1NC=N2 BTWUUHKQHOSMIN-UHFFFAOYSA-N 0.000 claims description 2
- CMYXTZPTHYRATM-UHFFFAOYSA-N 5-hydrazinyl-1,3-dimethylpyrazol-4-amine Chemical compound CC1=NN(C)C(NN)=C1N CMYXTZPTHYRATM-UHFFFAOYSA-N 0.000 claims description 2
- URGMLVWXPXSAKY-UHFFFAOYSA-N 5-methyl-1H-indol-4-ol Chemical compound CC1=CC=C2NC=CC2=C1O URGMLVWXPXSAKY-UHFFFAOYSA-N 0.000 claims description 2
- JSVCLRZBHIRDNZ-UHFFFAOYSA-N 5-methyl-2-phenylpyrazole-3,4-diamine Chemical compound NC1=C(N)C(C)=NN1C1=CC=CC=C1 JSVCLRZBHIRDNZ-UHFFFAOYSA-N 0.000 claims description 2
- CGTQMHXEGLHVFE-UHFFFAOYSA-N 5-methyl-2-propan-2-ylpyrazole-3,4-diamine Chemical compound CC(C)N1N=C(C)C(N)=C1N CGTQMHXEGLHVFE-UHFFFAOYSA-N 0.000 claims description 2
- NYEINRQDXMWWDE-UHFFFAOYSA-N 5-tert-butyl-2-methylpyrazole-3,4-diamine Chemical compound CN1N=C(C(C)(C)C)C(N)=C1N NYEINRQDXMWWDE-UHFFFAOYSA-N 0.000 claims description 2
- TUYBCLHMZFLWRY-UHFFFAOYSA-N 6-bromo-1,3-benzodioxol-5-ol Chemical compound C1=C(Br)C(O)=CC2=C1OCO2 TUYBCLHMZFLWRY-UHFFFAOYSA-N 0.000 claims description 2
- BKYQHRSVSLQLLQ-UHFFFAOYSA-N 6-methoxy-1,3-benzodioxol-5-amine Chemical compound C1=C(N)C(OC)=CC2=C1OCO2 BKYQHRSVSLQLLQ-UHFFFAOYSA-N 0.000 claims description 2
- LQAKMSIMGCYOAH-UHFFFAOYSA-N 6-methoxy-3H-benzimidazol-5-ol Chemical compound C1=C(O)C(OC)=CC2=C1NC=N2 LQAKMSIMGCYOAH-UHFFFAOYSA-N 0.000 claims description 2
- ULRSUUNKPNRHQW-UHFFFAOYSA-N 7-methyl-3H-benzimidazol-4-ol Chemical compound CC1=CC=C(O)C2=C1N=CN2 ULRSUUNKPNRHQW-UHFFFAOYSA-N 0.000 claims description 2
- RVWZJQLGEUQYMT-UHFFFAOYSA-N N1=C(C)C=C(O)N2N=CC(N)=C21 Chemical compound N1=C(C)C=C(O)N2N=CC(N)=C21 RVWZJQLGEUQYMT-UHFFFAOYSA-N 0.000 claims description 2
- FKPZNPIHLQPVGA-UHFFFAOYSA-N Nc1cc2OCOc2cc1CCO Chemical compound Nc1cc2OCOc2cc1CCO FKPZNPIHLQPVGA-UHFFFAOYSA-N 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 108090000437 Peroxidases Proteins 0.000 claims description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 2
- NFRGFILWUWNCOQ-UHFFFAOYSA-N ethyl 2-methyl-7-oxo-1H-pyrazolo[1,5-a]pyrimidine-6-carboxylate Chemical compound O=C1C(C(=O)OCC)=CN=C2C=C(C)NN21 NFRGFILWUWNCOQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000003840 hydrochlorides Chemical class 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 150000003893 lactate salts Chemical class 0.000 claims description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims description 2
- 230000002906 microbiologic Effects 0.000 claims description 2
- 101700041618 nhr-4 Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- FFNJDUZBKSGSIV-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine-3,5-diamine Chemical compound C1=CC(N)=NC2=C(N)C=NN21 FFNJDUZBKSGSIV-UHFFFAOYSA-N 0.000 claims description 2
- PZRKPUQWIFJRKZ-UHFFFAOYSA-N pyrimidine-2,4,5,6-tetramine Chemical compound NC1=NC(N)=C(N)C(N)=N1 PZRKPUQWIFJRKZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
- 150000003892 tartrate salts Chemical class 0.000 claims description 2
- KEUDMLLLHGLIGH-UHFFFAOYSA-N 1H-pyrazole;pyrimidine Chemical class C=1C=NNC=1.C1=CN=CN=C1 KEUDMLLLHGLIGH-UHFFFAOYSA-N 0.000 claims 2
- XXTAIXQMXAJWGO-UHFFFAOYSA-N 1-(2-hydroxyethyl)-5-methylindol-4-ol Chemical compound CC1=CC=C2N(CCO)C=CC2=C1O XXTAIXQMXAJWGO-UHFFFAOYSA-N 0.000 claims 1
- MIMYTSWNVBMNRH-UHFFFAOYSA-N 1H-indol-6-amine Chemical compound NC1=CC=C2C=CNC2=C1 MIMYTSWNVBMNRH-UHFFFAOYSA-N 0.000 claims 1
- MMQJZQKFTWIATR-UHFFFAOYSA-N 1H-pyrazole;1H-pyrrole Chemical class C=1C=CNC=1.C=1C=NNC=1 MMQJZQKFTWIATR-UHFFFAOYSA-N 0.000 claims 1
- MRQOOXQWSNRMAM-UHFFFAOYSA-N 2,5-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine Chemical compound NC1=CC(C)=NC2=C(N)C(C)=NN21 MRQOOXQWSNRMAM-UHFFFAOYSA-N 0.000 claims 1
- LGZOJZFHAJJLCF-UHFFFAOYSA-N 2,7-dimethylpyrazolo[1,5-a]pyrimidine-3,5-diamine Chemical compound CC1=CC(N)=NC2=C(N)C(C)=NN21 LGZOJZFHAJJLCF-UHFFFAOYSA-N 0.000 claims 1
- OIAATOHBNVCLJY-UHFFFAOYSA-N 2-[(3-amino-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino]ethanol Chemical compound N1=C(C)C=C(NCCO)N2N=CC(N)=C21 OIAATOHBNVCLJY-UHFFFAOYSA-N 0.000 claims 1
- ATBJHESGXAEWOU-UHFFFAOYSA-N 2-[(3-aminopyrazolo[1,5-a]pyrimidin-7-yl)-(2-hydroxyethyl)amino]ethanol Chemical compound OCCN(CCO)C1=CC=NC2=C(N)C=NN21 ATBJHESGXAEWOU-UHFFFAOYSA-N 0.000 claims 1
- ZQLZWNDBBQUIEY-UHFFFAOYSA-N 2-[(7-aminopyrazolo[1,5-a]pyrimidin-3-yl)-(2-hydroxyethyl)amino]ethanol Chemical compound NC1=CC=NC2=C(N(CCO)CCO)C=NN12 ZQLZWNDBBQUIEY-UHFFFAOYSA-N 0.000 claims 1
- LRFYRWUMJLXTJH-UHFFFAOYSA-N 2-ethyl-5-(4-methoxyphenyl)pyrazole-3,4-diamine Chemical compound NC1=C(N)N(CC)N=C1C1=CC=C(OC)C=C1 LRFYRWUMJLXTJH-UHFFFAOYSA-N 0.000 claims 1
- FUSOVLABBHPMLG-UHFFFAOYSA-N 3-amino-1H-pyrazolo[1,5-a]pyrimidin-7-one Chemical compound NC1=CNN2C1=NC=CC2=O FUSOVLABBHPMLG-UHFFFAOYSA-N 0.000 claims 1
- WLSFMPWGCOPING-UHFFFAOYSA-N 4-methyl-2,3-dihydro-1,4-benzoxazin-6-ol Chemical compound C1=C(O)C=C2N(C)CCOC2=C1 WLSFMPWGCOPING-UHFFFAOYSA-N 0.000 claims 1
- XIVKOHKRYXQJHX-UHFFFAOYSA-N C(C)C=1C(=CC=C2C=C(NC=12)N)CCO Chemical compound C(C)C=1C(=CC=C2C=C(NC=12)N)CCO XIVKOHKRYXQJHX-UHFFFAOYSA-N 0.000 claims 1
- ZYIRBDMSLWVGTQ-UHFFFAOYSA-N Nc1ccc2c(c1)[nH]c1ccnn21 Chemical compound Nc1ccc2c(c1)[nH]c1ccnn21 ZYIRBDMSLWVGTQ-UHFFFAOYSA-N 0.000 claims 1
- 229940072417 Peroxidase Drugs 0.000 claims 1
- 125000005466 alkylenyl group Chemical group 0.000 claims 1
- RQGPLDBZHMVWCH-UHFFFAOYSA-N pyrrolo[3,2-b]pyrrole Chemical class C1=NC2=CC=NC2=C1 RQGPLDBZHMVWCH-UHFFFAOYSA-N 0.000 claims 1
- 101700002057 STORR Proteins 0.000 abstract 1
- 239000000975 dye Substances 0.000 description 68
- 239000002585 base Substances 0.000 description 18
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 230000001590 oxidative Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000004040 coloring Methods 0.000 description 5
- 239000002453 shampoo Substances 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010001816 EC 1.1.3.10 Proteins 0.000 description 3
- 108010015776 EC 1.1.3.4 Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000004059 degradation Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 108010073450 EC 1.13.12.4 Proteins 0.000 description 2
- 108010042687 EC 1.2.3.3 Proteins 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000282372 Panthera onca Species 0.000 description 2
- 102000014961 Protein Precursors Human genes 0.000 description 2
- 108010078762 Protein Precursors Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 230000003113 alkalizing Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- BWKOZPVPARTQIV-UHFFFAOYSA-N azanium;hydron;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [NH4+].OC(=O)CC(O)(C(O)=O)CC([O-])=O BWKOZPVPARTQIV-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000003750 conditioning Effects 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 230000002255 enzymatic Effects 0.000 description 2
- 108010090622 glycerol oxidase Proteins 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000003389 potentiating Effects 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- LKDRXBCSQODPBY-AMVSKUEXSA-N (3S,4R,5S)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- LEDXVVSZBQRIKT-UHFFFAOYSA-N 1,2-diethylpyrazolidine-3,5-dione Chemical compound CCN1N(CC)C(=O)CC1=O LEDXVVSZBQRIKT-UHFFFAOYSA-N 0.000 description 1
- XDPKQGKEOCYMQC-UHFFFAOYSA-N 1,2-diphenylpyrazolidine-3,5-dione Chemical compound O=C1CC(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 XDPKQGKEOCYMQC-UHFFFAOYSA-N 0.000 description 1
- XYALCRZTZJUWNZ-UHFFFAOYSA-N 1-(2-hydroxyethyl)indol-4-ol Chemical compound C1=CC=C2N(CCO)C=CC2=C1O XYALCRZTZJUWNZ-UHFFFAOYSA-N 0.000 description 1
- ZJMUBINEQIUUPL-UHFFFAOYSA-N 1-butylbenzimidazol-4-ol Chemical compound C1=CC=C2N(CCCC)C=NC2=C1O ZJMUBINEQIUUPL-UHFFFAOYSA-N 0.000 description 1
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
- VFFKUMJVZWLOQM-UHFFFAOYSA-N 2,6-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine Chemical compound NC1=C(C)C=NC2=C(N)C(C)=NN21 VFFKUMJVZWLOQM-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-Butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- RHIPXPBQVGXJNL-UHFFFAOYSA-N 2-[(3-aminopyrazolo[1,5-a]pyrimidin-7-yl)amino]ethanol Chemical compound OCCNC1=CC=NC2=C(N)C=NN21 RHIPXPBQVGXJNL-UHFFFAOYSA-N 0.000 description 1
- GYMLMGZEWCBQSE-UHFFFAOYSA-N 2-ethyl-3H-pyrazolo[1,5-b][1,2,4]triazole Chemical compound N1=CC=C2NC(CC)=NN21 GYMLMGZEWCBQSE-UHFFFAOYSA-N 0.000 description 1
- PJAKDGBANXXCFX-UHFFFAOYSA-N 2-methyl-3H-pyrazolo[1,5-b][1,2,4]triazole Chemical compound N1=CC=C2NC(C)=NN21 PJAKDGBANXXCFX-UHFFFAOYSA-N 0.000 description 1
- MWXUGXZKBKIMKB-UHFFFAOYSA-N 2-methylpyrazolo[1,5-a]pyrimidine-3,7-diamine Chemical compound NC1=CC=NC2=C(N)C(C)=NN21 MWXUGXZKBKIMKB-UHFFFAOYSA-N 0.000 description 1
- MCGBIXXDQFWVDW-UHFFFAOYSA-N 4,5-dihydro-1H-pyrazole Chemical class C1CC=NN1 MCGBIXXDQFWVDW-UHFFFAOYSA-N 0.000 description 1
- DMBUAGDHNUPLRA-UHFFFAOYSA-N 5,6-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine Chemical compound NC1=C(C)C(C)=NC2=C(N)C=NN21 DMBUAGDHNUPLRA-UHFFFAOYSA-N 0.000 description 1
- VHHWHDFVZGPKRT-UHFFFAOYSA-N 5H-pyrazolo[3,4-d][1,3]thiazole Chemical class N1=NC2=NCSC2=C1 VHHWHDFVZGPKRT-UHFFFAOYSA-N 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N Aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 241000186074 Arthrobacter globiformis Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- BGMAIXRJQFTHIH-UHFFFAOYSA-N C1=CC(O)=NC2=C(N)C=NN21 Chemical compound C1=CC(O)=NC2=C(N)C=NN21 BGMAIXRJQFTHIH-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N Dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 229940120503 Dihydroxyacetone Drugs 0.000 description 1
- 229940116332 GLUCOSE OXIDASE Drugs 0.000 description 1
- 229960001031 Glucose Drugs 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- PKACFTKQQUDJDA-UHFFFAOYSA-N OC1=CC=NC2=C(N)C=NN21 Chemical compound OC1=CC=NC2=C(N)C=NN21 PKACFTKQQUDJDA-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N P-Phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229960005323 Phenoxyethanol Drugs 0.000 description 1
- 229940107700 Pyruvic Acid Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229910052803 cobalt Inorganic materials 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000001143 conditioned Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000001808 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000982 direct dye Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical class OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000149 penetrating Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- UBUFOHLVTQZEQF-UHFFFAOYSA-N pyridine-2,3,4,6-tetramine Chemical compound NC1=CC(N)=C(N)C(N)=N1 UBUFOHLVTQZEQF-UHFFFAOYSA-N 0.000 description 1
- MIROPXUFDXCYLG-UHFFFAOYSA-N pyridine-2,5-diamine Chemical compound NC1=CC=C(N)N=C1 MIROPXUFDXCYLG-UHFFFAOYSA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000002110 toxicologic Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
The invention concerns a ready-for-use keratin fibre oxidation dyeing composition, in particular for human keratin fibres such as hair, comprising, in a medium suitable for dyeing, at least a heterocyclic oxidation dye, at least an oxydoreductase enzyme with 2 electrons in the presence of at least a donor for said enzyme, and the dyeing method using said composition.
Description
COMPOSITION OF DYEING BY OXIDATION OF KERATINIC FIBERS AND DYEING PROCEDURE USED
THIS COMPOSITION.
The subject of the invention is a composition for the oxidation dyeing of keratin fibers, and in particular of human keratin fibers such as hair comprising, in a medium suitable for dyeing, at least one heterocyclic oxidation dye, at least a 2-electron oxide-reductase-type enzyme in the presence of at least one donor for the indicated enzyme, as well as the dyeing process using this composition. It is known to dye keratin fibers and in particular human hair with dyeing compositions containing dye precursors by oxidation, in particular ortho or paraphenylenediamines, ortho or para-aminophenols, heterocyclic bases, generally called oxidation bases. Oxidation dye precursors, or oxidation bases, are colorless or weakly colored compounds which, associated with oxidizing products, can give rise to colored compounds and dyes by a process of oxidative condensation. It is also known that the
EF: 32067 shades obtained with these oxidation bases associating them with copulators or color modifiers, the latter being chosen in particular between aromatic meta-diamines, meta-aminophenols, meta-diphenols and some heterocyclic compounds. The variety of molecules used at the level of oxidation bases and copulators allows obtaining a rich range of colors. The coloration called "permanent" obtained thanks to these oxidation dyes, must on the other hand meet a certain number of requirements. Thus, it should have no drawbacks on the toxicological level, it should allow obtaining tonalities in the desired intensity and present a good behavior with respect to external agents (light, bad weather, washing, perm, perspiration, friction). The dyes must likewise make it possible to cover the white hairs, and finally to be as less selective as possible, that is to say, to obtain a difference in coloration as low as possible throughout the same keratin fiber, which may be in differently sensitized effect (i.e. , spoiled) between its tip and its root. The oxidation coloring of the keratin fibers is generally carried out in an alkaline medium in the presence of hydrogen peroxide, however, the use of alkaline media in the presence of hydrogen peroxide has the drawback of producing a non-negligible degradation of the fibers, as well as a discoloration of the keratin fibers which is not always desirable.The oxidation coloring of the keratin fibers can also be carried out with the aid of oxidizing systems other than hydrogen peroxide such as enzymatic systems.Thus it has already been proposed to dye the fibers keratin preparations, particularly in the patent application EP-A-0310,675, with compositions comprising a benzene-type oxidation dye precursor, in association with enzymes such as pyranose oxidase, glucose oxidase or uricase, in the presence of of a donor for the indicated enzymes.These dyeing procedures, although they are carried out under conditions which do not produce a degradation of the keratin fibers comparable to that produced by the dyeings carried out in the presence of hydrogen peroxide, they lead to less strong deposits. However, the applicant now finishes discovering that it is possible to obtain new dyes, able to lead to strong colorations without producing significant degradation, or discoloration of the keratin fibers, which are not very selective and which resist the various aggressions that the hair may experience. , associating at least one oxidation base, at least one copulant, and at least one 2-electron oxide-reductase type enzyme in the presence of at least one donor for the indicated enzyme, the oxidation base (s) and / or the coupling (s) used being chosen from appropriately selected heterocyclic compounds. This discovery forms the basis of the present invention. The invention therefore has as its first object a ready-to-use composition for the oxidation dyeing of keratin fibers and in particular of human keratin fibers such as hair, which comprises the combination of at least one oxidation base and the less a copulator, characterized in that it comprises, in a medium suitable for dyeing, at least one 2-electron oxide-reductase-type enzyme in the presence of at least one donor for said enzyme, and because said base of oxidation and / or the indicated copulant is chosen from the heterocyclic compounds to the exclusion of the monocyclic pyridine compounds. The ready-to-use dye composition according to the invention leads to more potent colorations than those obtained with dye compositions containing only benzene dyes in the presence of a 2-electron oxido-reductase-type enzyme, and of a donor for the indicated enzyme, which is not the case with a 'classic oxidant system such as peroxide
I hydrogen The colorations obtained with the ready-to-use dye composition composition according to the invention have, on the other hand, low selectivity and excellent properties of resistances at the same time with respect to atmospheric agents such as light and weathering and with respect to perspiration and different treatments. that can experience the hair (washes, deformations
1 permanent). The subject of the invention is also a process for dyeing by oxidation keratin fibers using this ready-to-use dye composition. The 2-electron oxido-reductases used in the ready-to-use dye composition according to the invention can be chosen in particular from pyranose oxidases, glucose oxidases, glycerol oxidases, lactate oxidases, pyruvate oxidases, and uricasas According to the invention, the 2-electron oxido-reductase is preferably chosen from uricases of animal, microbiological or biotechnological origin.
By way of example, one can particularly mention the uricase extracted from boar liver, the uricase from Arthrobacter globiformis, as well as the uricase from Aspergillus flavus. The 2-electron oxido-reductases can be used in pure crystalline form or in a dilute form in an inert diluent for the indicated 2-electron oxido-reductase. The 2-electron oxide-reductases according to the invention preferably represent from 0.01 to 20% by weight approximately of the total weight of the ready-to-use dye composition, and even more preferably from 0.1 to 5% by weight approximately of this weight. According to the invention, "donor" is understood to mean the different substrates equally necessary for the operation of the indicated one or of said 2-electron oxido-reductases. The nature of the donor (or substrate) for the indicated enzyme varies depending on the nature of the 2-electron oxido-reductase that is used. For example, as a donor for the pyranose oxidases, mention may be made of D-glucose, L-sorbose and D-xylose; as a donor for glucose oxidases, D-glucoses can be mentioned, as a donor for glycerol oxidases, there may be mentioned glycerol and dihydroxyacetone; as a donor for lactate oxidases, mention may be made of lactic acid and its salts; as a donor for pyruvate oxidases, mention may be made of pyruvic acid and its salts; and finally as a donor for uricasas, we can mention uric acid and its salts. The donor (s) (s) used according to the invention preferably represent 0.01 to 20% by weight approximately of the total weight of the dye composition ready for use according to the invention and even more preferably from 0.1 to 5% approximately this weight. Among the heterocyclic oxidation bases which can be used in the ready-to-use dye composition according to the invention, mention may be made, in particular, of the pyrimidine derivatives, the pyrazole derivatives and their addition salts with an acid. Among the pyrimidine derivatives, mention may be made more particularly of the compounds described, for example, in German Patents 2,359,399 or Japanese Patents JP 88-169,571 and JP 91-106-059, such as 2,4,5,6-tetraaminopyridine, 4-hydroxy-2, 5,6-triaminopyrimidine, and its addition salts with an acid, as well as the pyrazolopyrimidine derivatives such as pyrazolo- [1,5-a] -pyrimidine-3,7-diamine, 2- methyl pyrazolo- [1, 5-a] -pyrimidine-3,7-diamine, 2-5-dimethylpyrazolo- [1, 5-a] -pyrimidine-3,7-diamine, pyrazolo- [1, 5 -a] pyrimidine-3, 5-diamine, 2,7-dimethylpyrazolo- [1, 5-a] pyrimidine-3-5-diamine, 3-amino pyrazolo- [1, 5-a] -pyrimidine- 7-ol, 3-amino 5-methyl pyrazolo- [1, 5-a] -pyrimidin-7-ol, 3-amino pyrazolo- [1, 5-a] -pyrimidin-5-ol, 2 - (3-amino pyrazolo- [1, 5-a] -pyrimidin-7-ylamino) -ethanol, 3-amino-7-β-hydroxyethylamine-5-methyl-pyrazolo- [1, 5-a] -pyrimidine, 2- (7-amino pyrazolo- [1,5-a] -pyrimidin-3-ylamino) -ethanol, 2- [(3-amino-pyrazolo- [1,5-a] ] -pyrimidin-7-yl) - (2-hydroxyethyl) -amino] -ethanol, 2- [(7-amino-pyrazolo- [1, 5 a] -pyrimidin-3-yl) - (2-hydroxyethyl) ) -amino] -ethanol, 5,6-dimethylpyrazolo- [1,5-a] -pyrimidine-3,7-diamine, 2,6-dimethylpyrazolo- [1,5-a] -pyrimidine-3, 7-diamine, 2,5, N-7-tetramethyl pyrazolo- [1,5-a] -pyrimidine-3,7-diamine, and their addition salts and their tautomeric forms, when there is a tautomeric equilibrium. Among the pyrazole derivatives, the compounds described in the patents or patent applications DE 3,843,892, DE 4,133,957, DE 4,234,886, DE 4,234,887, FR 2,733,749, FR 2,735,685, can be cited more particularly. WO 94/08969 and WO 94/08970, such as 4,5-diamino pyrazole, 4,5-diamino-1-methyl pyrazole, 1-benzyl 4,5-diamino pyrazole, 3,4-diamino pyrazole, 1-benzyl 4,5-diamino-3-methyl pyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 4,5-diamino-3-methyl-1-phenyl-pyrazole, 4,5-diamino-3-methyl 1-tert-butyl pyrazole, 4,5-diamino-1-methyl-3-tert-butyl pyrazole, 4,5-diamino-1-ethyl-3-methyl-pyrazole, 4,5-dia-tert-1-ethyl 3- (4 * -methoxyphenyl) pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethyl pyrazole, 4,5-diamino-3-hydroxymethyl-1-methyl-pyrazole, 4,5-diamino-3-hydroxymethyl-1-isopropyl pyrazole, 4,5-diamino-3-methyl-1-isopropyl pyrazole, and its addition salts with an acid. When present, the heterocyclic oxidation base or bases according to the invention preferably represent from 0.0005 to 12% by weight approximately of the total weight of the ready-to-use dye composition, and even more preferably from 0.005 to 6% by weight approximately of this weight. Among the heterocyclic couplers which can be used in the ready-to-use dye composition according to the invention, mention may be made in particular of the indole derivatives, the indoline derivatives, the benzimidazole derivatives, the benzomorpholine derivatives, the sesamol derivatives, the pyrazole-azolic derivatives, pyrrolozole derivatives, imidazole-azole derivatives, pyrazolo-pyrimidine derivatives, pyrazolin-3, 5-diones derivatives, pyrrolo- [3, 2-d] -oxazole derivatives, pyrazole derivatives [3, 4-d] -thiazoles, the thiozole-azolic S-oxide derivatives, the S, S-dioxide-thiazole-azolic derivatives, and their addition salts with an acid. Among the indole derivatives which can be used as heterocyclic couplers in the dyeing composition according to the invention, mention may be made more particularly of the compounds of the following formula (I) and their addition salts with an acid:
wherein Rx represents a hydrogen atom, an alkyl radical of
C? ~ C4, a mono- or polyhydroxyalkyl radical of C2-C or aminoalkyl of Cj.-C4 whose amine is mono- or disubstituted by an alkyl group of C? _C4; R 2 represents a hydrogen atom or a C 1 -C 4 alkyl radical; R3 represents a hydrogen atom, an alkyl radical of
C-C4 O hydroxyl; X represents a hydroxyl radical or NHR4 in which R4 represents a hydrogen atom, an alkyl radical of C? -C4 or hydroxyalkyl of C? ~ C4.
Among the indole compounds of formula (I) indicated above, one may more particularly cite 4-hydroxy indole, 6-hydroxy indole, 7-amino indole,
6-a.mip.o indole, 7-hydroxy indole, 7-ethyl 6- (ß-hydroxyethyl) amino indole, 4-amino indole, 6-hydroxy-1-methyl indole, 5,6-dihydroxy indole, 4-hydroxy 1-N-methyl indole, 4-hydroxy 2-methyl indole, 4-hydroxy 5-methyl indole, 4-hydroxy 1-N- (ß-hydroxyethyl) indole, 4-hydroxy 1-N- (ß-hydroxypropyl) indole, lN- (ß,? - dihydroxypropyl) 4-hydroxy indole, 4-hydroxy-lN- (ß-hydroxyethyl) -5-methyl indole, 1-N- (? - dimethylaminopropyl) 4-hydroxy indole, and its addition salts with an acid. Among the indoline derivatives usable as heterocyclic couplers in the. dye composition according to the invention, mention may be made in particular of 4-hydroxy indoline, 6-hydroxy indoline, 6-amino indoline, 5,6-dihydroxy indoline, and their addition salts with an acid. Among the benzimidazole derivatives which can be used as heterocyclic couplers in the dye composition according to the invention, the following compounds of formula (II) and their addition salts with an acid can be mentioned more particularly:
wherein Rs represents a hydrogen atom or an alkyl radical of
C? ~ C, R6. represents a hydrogen atom, an alkyl radical of C? -C4 or phenyl, R7 represents a hydroxyl, amino or methoxy radical, Re represents a hydrogen atom, a hydroxyl radical, methoxy or C? -C4 alkyl; with the proviso that - when R7 designates an amino radical, then it occupies position 4, - when R? occupies position 4. then Rs occupies position 7, - when R7 occupies position 5. then R8 occupies position 6. Among the benzimidazole derivatives of formula
(II) indicated above, can more particularly be mentioned 4-hydroxybenzimidazole, 4-amino benzimidazole, 4-hydroxy-7-methylbenzimidazole, 4-hydroxy-2-methylbenzimidazole, 1-butyl-4-hydroxybenzimidazole, 4-amino-2-methyl-benzimidazole, 5,6-dihydroxy-benzimidazole, 5-hydroxy-6-methoxy-benzimidazole, 4,7-dihydroxy-benzimidazole, 4,7-dihydroxy-1-methyl-benzimidazole, 4,7 -dimethoxy benzimidazole, 5,6-dihydroxy-1-methyl benzimidazole, 5,6-dihydroxy-2-methyl-benzimidazole, 5,6-dimethoxy-benzimidazole, and their addition salts with an acid. Among the benzomorpholine derivatives which can be used as heterocyclic couplers in the ready-to-use dye composition according to the invention, mention may be made more particularly of the compounds of formula (III) below, and their addition salts with an acid.
wherein: R9 and R10, identical or different, represent a hydrogen atom or an alkyl radical of C? ~ C, Z represents a hydroxyl or amino radical. Among the benzomorpholine derivatives of formula
(III) indicated above, can be more particularly cited 6-hydroxy 1,4-benzomorpholine, N-methyl 6-hydroxy-1-4-benzomorpholine, 6-amino 1,4-benzomorpholine, and its addition salts with an acid Among the sesamol derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the following compounds of formula (IV) and their addition salts with an acid can be mentioned in particular:
wherein: Ru designates a hydroxyl radical, amino (C? -C4) amino, monohydroxyalkyl (C? ~ C) amino ~ or polyhydroxyalkyl (C2-C) amino, Rx2 designates a hydrogen or halogen atom or a C? -C alkoxy radical. __ -Among the sesamol derivatives of formula (IV) indicated above, mention may be made more particularly of 2-bromo-4,5-methylenedioxy phenol, 2-methoxy-4,5-methylenedioxy aniline, 2- (β-hydroxyethyl) amino 4,5-methylenedioxy benzene, and its addition salts with an acid. - Among the pyrazolo-azolic derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in the following patent and patent applications can be cited more particularly: FR 2,075,583, EP- A-119,860, EP-A-285,274, EP-A-244,160, EP-A-578,248, GB 1,458,377, US 3,227,554, US 3,419,391, US 3,061,432, US 4,500,630, US 3,725. .067, US 3,926,631, US 5,457,210, JP 84/99437, JP 83/42045, JP 84/162548, JP 84/171956, JP 85/33552, JP 85/43659, JP 85/172982, JP 85 / 190779_ as well as in the following publications: Chem. Ber. 32, 797 (1899), Chem. Ber. 89, 2550, (1956), J. Chem, Soc. Perkin trans I, 2047, (1977), J. Prakt. Chem., 320, 533, (1978); whose teachings form an integral part of the present application. As the pyrazolozole derivatives, mention may be made in particular of: 2-methyl pyrazolo [1, 5-b] -1,2,4-triazole, 2-ethyl pyrazolo [1,5-b] -1, 2, 4-triazole, - 2-isopropyl pyrazolo [1, 5-bl -1,2, 4-triazole, - 2-phenyl-pyrazolo [1, 5-b] -1, 2, -triazole , - 2,6-dimethylpyrazolo [1,5-b] -1,2,4-triazole, - 7-chloro-2,6-dimethylpyrazolo [1,5-b] -1,2-triazole ,
- 3,6-dimethyl-pyrazolo [3,2-c] -1,2,4-triazole - 6-phenyl-3-methylthio-pyrazolo [3, 2-c] -1, 2, 4- triazole, - 6-amino-pyrazolo [1,5-a] benzimidazole, and its addition salts with an acid. Among the pyrrolozole derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in the following patent and patent applications can be cited more particularly: US 5,256,526, EP-A -557,851, EP-A-578,248, EP-A-518,238, EP-A-456,226, EP-A-488-909, EP-A-488-248, and in the following publications: - DR Liljegren Ber. 1964, 3436; - E.J. Bro ne, J.C.S., 1962, 5149; - P. Magnus, J.A.C.S., 1990, 112, 2465; - P. Magnus, J.A.C.S., 1987, 109, 2711; - Angew. Chem. 1960, 72, 9'56; - and Rec. Trav. Chim. 1961, 80, 1075; whose teachings form an integral part of the present application. As pyrrolozole derivatives, the following may be particularly mentioned: - 5-cyano-4-ethoxycarbonyl-8-methyl pyrrolo [1,2-b '] -1,2,4-triazole, - cyano-8-methyl-4-phenyl pyrrolo [1,2-b] -1,2,4-triazole,
7-amido-6-ethoxycarbonyl pyrrolo [1,2-a] -benzimidazole and its addition salts with an acid. Among the imidazolezole derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in the following patent and patent applications can be cited more particularly: US Pat. No. 5,441,863; JP 62-279-337; JP 06-236 011 and JP 07-092 632, whose teachings form an integral part of the present application. As imidazole-azole derivatives, the following may particularly be mentioned: 7,8-dicyano-imidazole [3, 2-a] -imidazole, 7,8-dicyano-4-rnethyl-imidazole [3] , 2-a] -imidazole, and its addition salts with an acid. Among the pyrazolo-pyrimidine derivatives which can be used as the heterocyclic copolymer in the ready-to-use dye composition according to the invention. more particularly, the compounds described in the following patent application can be cited: EP-A-304,001 the teachings of which form an integral part of the present application. As pyrazolo-pyrimidine derivatives, the following may be particularly mentioned: - pyrazolo [1,5-a] pyrimidin-7-one, - 2,5-dimethylpyrazolo [1,5-a] pyrimidin-7-one , 2-methyl-6-ethoxycarbonyl pyrazolo [1,5-a] pyrimidin-7-one, - 2-methyl-5-methoxymethyl pyrazolo [1,5-a] pyrimidin-7-one, - 2- tert-butyl-5-trifluoromethylpyrazolo [1, 5-a] pyrimidin-7-one, - 2,7-dimethylpyrazolo [1,5-a] pyrimidin-5-one, and its addition salts with an acid. Among the 3, 5-pyrazoline derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in the following patent and patent applications can be mentioned more particularly: JP 07- 036159, JP 07-84348 and US 4,128,425, and in the following publications: - L. WYZGOWSKA, Acta. Pol. Pharm. 1982, 39 (1-3), 83. - E HANNIG, Phar azie, 1980, 35 (4), 231 - M. H. ELNAGDI, Bull. Chem. Soc. Jap., 46 (6), 1830, 1973 - G. CARDILLO, Gazz, Chim, Itai. 1966, 96, (8-9), 973. whose teachings form an integral part of the present application. As the 3, 5-pyrazoline dione derivatives, mention may be made particularly of: 1,2-diphenyl 3,5-pyrazoline dione, 1,2-diethyl 3,5-pyrazoline dione and its salts addition with an acid. Among the pyrrolo- [3, 2-d] -oxazole derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in the patent application JP 07 325 can be cited more particularly. 375 whose teachings form an integral part of the present application. Among the pyrazolo- [3,4-d] -thiazole derivatives which can be used as the heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in the patent applications JP 07 244 361 can be cited more particularly. and in J. Heterocycl. Chem. 16, 13, (1979). Among the S-oxide-thiazolo-azole and S, S-dioxide-thiazole-azole derivatives which can be used as a heterocyclic coupler in the ready-to-use dye composition according to the invention, the compounds described in US Pat. following documents: - JP 07 098489; - Khim. Geterotsilk, Soedin, 1967, page 93; - J. Prakt. Chem., 318, 1976, page 12; - Indian J. Heterocycl. Chem. 1995, 5 (2), page 135; - Act. Pol. Pharm. 1995, 52 (5), 415; - Heterocycl. Commun. 1995, 1 (4), 297; Arch. Pharm. (Weinheim, Ger.), 1994, 327 (12), 825. When present, this or these heterocyclic copulators preferably represent from 0.0001 to 10% by weight approximately of the total weight of the ready-to-use dye composition and even more preferably from 0.005 to 5% by weight approximately of this weight. The ready-to-use dye composition according to the invention can also contain, in addition to the dyes defined above, other oxidation bases and / or other couplers and / or other dyes, such as for example direct dyes, in particular for modifying the tones or enriching them with reflexes. Among the oxidation bases which may be present additionally in the ready-to-use dye composition according to the invention, mention may be made in particular of the paraffinylenes inas, the bis-phenylalkylenediamines, the orthophenylenediamines, the para-aminophenols, the ortho-aminophenols, and their addition salts with an acid. When used, these additional oxidation bases preferably represent from 0.0005 to 12% by weight approximately of the total weight of the dyeing composition, and even more preferably from 0.005 to 6% by weight approximately of this weight. Among the copulators which may additionally be present in the ready-to-use dye composition according to the invention, mention may be made in particular of meta-phenylenediarrines, meta-aminophenols, meta-diphenols and their addition salts with an acid. When these additional couplers are present they preferably represent from 0.0001 to 10% by weight approximately of the total weight of the ready-to-use dye composition and even more preferably from 0.005 to 5% by weight approximately of this weight. In a general manner, the addition salts with an acid which can be used in the framework of the dyeing compositions of the invention (oxidation bases and couplers) are particularly chosen from hydrochlorides, hydrobromides, sulfates and tartrates, lactates and acetates. The suitable medium for the dye (or support) of the ready-to-use dye composition according to the invention is generally constituted by water or by a mixture of water and by at least one organic solvent to solubilize the compounds that were not sufficiently soluble in the composition. Water. As the organic solvent, mention may be made, for example, of C?-C 4 alkanols, such as ethanol and isopropanol; glycerol; glycols and ethers of glycols such as 2-butoxyethanol, propylene glycol, monomethylether of propylene glycol, monoethylether and monomethylether of diethylene glycol, as well as aromatic alcohols such as benzyl alcohol or phenoxyethanol, analogous products and mixtures thereof. The solvents can be present in proportions, preferably between 1 and 40% by weight, based on the total weight of the dyeing composition, and even more preferably between 5 and 30% by weight. The pH of the ready-to-use composition according to the invention is chosen in such a way that the enzymatic activity of the 2-electron oxido-reductase is not altered. Generally it is comprised between 5 and 11 approximately, and preferably between 6.5 and 10 approximately. It can be adjusted to the desired value by means of acidifying or alkalizing agents usually used in the dyeing of keratin fibers. Among the acidulating agents, mention may be made, by way of example, of mineral or organic acids such as hydrochloric acid, orthophosphoric acid, sulfuric acid, carboxylic acids such as acetic acid, tartaric acid, citric acid, acid lactic, sulfonic acids. Among alkalizing agents, mention may be made, by way of example, of ammonia, alkali metal carbonates, alkanolamines such as mono-, di- and triethanolanes, 2-methyl-2-aminopropanol as well as their derivatives, hydroxides of sodium or potassium and the compounds of formula (V) below:
wherein W is a propylene moiety optionally substituted by a hydroxyl group or an alkyl radical of C? -C4; R? 3, RI4? R and Ri 6f identical or different represent a hydrogen atom, a C 1 -C 4 alkyl radical or a C 1 -C 4 hydroxyalkyl radical. The ready-to-use dye composition according to the invention can also include various adjuvants conventionally used in dyeing compositions for hair, such as anionic, cationic, non-ionic, amphoteric, zwitterionic surfactants or mixtures thereof, polymers anionic, canonic, non-ionic, amphoteric, zwitterionic or their mixtures, mineral or organic thickeners, agents
'Antioxidants, enzymes different from the 2-electron oxido-reductases used according to the invention such as for example peroxidases, penetrating agents, sequestering agents, perfumes buffers, dispersing agents, conditioning agents such as for example silicones, smoke-killing agents, Preservative agents, opacifying agents It is understood that the person skilled in the art will try to choose this or these possible complementary compounds in such a way that the advantageous properties intrinsically related to the ready-to-use dye composition according to the invention are not, or substantially, altered by the additive (s) under consideration The ready-to-use dye composition according to the invention can be presented in various forms, such as in the form of liquids, creams, gels, optionally pressurized, or in any other suitable form "for a dyeing of the keratin fibers, and particular mind the human hair. In this case, the oxidation dye (s) and the 2-electron oxido-reductases are present within the same composition ready for use, and therefore said composition must be free of gaseous oxygen, in order to avoid all premature oxidation of the colorant (s) by oxidation. The subject of the invention is also a process for dyeing keratin fibers and in particular human keratin fibers such as hair using the ready-to-use dye composition as defined above. According to this process, at least one ready-to-use dye composition is applied on the fibers as defined above, for a sufficient time to develop the desired coloration, after which it is rinsed, washed optionally with shampoo, The time necessary for the development of the coloration on the keratin fibers is generally between 3 and 60 minutes and even more precisely between 5 and 40 minutes According to a particular embodiment of the invention, the The method comprises a "preliminary step" consisting in separately storing, on the one hand, a composition (A) comprising, in a medium suitable for dyeing, at least one base of heterocyclic oxidation as defined above and / or at least one heterocyclic coupler as defined above and, on the other hand, a composition (B) including, in a medium suitable for dye, at least one 2-electron oxido-reductase-type enzyme in the presence of at least one donor for the indicated enzyme, then it would be mixed at the time of use before applying this mixture on the keratin fibers.
The "compositions A and B according to the invention can be conditioned in a multi-compartment device or dyeing kit or any other multi-compartment conditioning system of which a first compartment includes the composition (A) such as the one defined above and a second compartment includes the composition (B) as defined above. These devices can be equipped with a means for supplying the desired mixture to the hair, such as the devices described in patent FR-2,586,913 in the name of the applicant. The following examples are intended to illustrate the invention without thereby limiting the scope.
EXAMPLES
COMPARATIVE EXAMPLES 1 AND 2 The following ready-to-use dye compositions were prepared (contained in grams)
(*) Example that does not form part of the invention (**): Common dyeing support: -. Ethanol "- 10.0 g - Hydroxypropylated guar gum sold under the designation JAGUAR HP 60 by the Company MAYHA, LL 0.8 g
- Alkyl (Cß-Cio) polyglucoside in 60% aqueous solution of active material (M.A.) buffered by ammonium citrate (0.5%), sold under the name ORAMIX CG110. by the Society SC 8.0 g
- Monoethanolamine c.s pH = 9.5 It is important to appreciate that each of the ready-to-use dye compositions described above contain the same molar amount of each of the oxidation bases, namely 3.10-3 moles. Each of the ready-to-use dye compositions described above was applied to natural gray hair strands at 90% white for 30 minutes. The hair was then rinsed, washed with a standard shampoo, then dried. The color of the wicks was then evaluated before and after coloring in the MUNSELL system by means of a CM 2002 MINOLTA colorimeter in order to determine the strength of the placements obtained with each of the compositions described above. The difference between the color of the wick before dyeing and the color of the wick after dyeing was calculated by applying the NICKERSON formula:? E = 0.4 Co? H + 6? V + 3? C such as that described by example in "Couleur, Industrie et Techmque"; pages 14-17; vol. No. 5; 1978. In this formula? E represents the color difference between two wicks,? H,? Vy? C represent the variation in absolute value of the parameters H, V and C and Co represents the purity of the wick in relation to which you want to evaluate the color difference. The strength of coloration (? E) is all the more important the higher the figure indicated.
The results are given in Table I given below: Table I
(*): Example that is not part of the invention. These results show that in the presence of the Uricase / Uric Acid oxidizing system, the "ready-to-use dye composition for example 1 which does not form part of the invention as it contains no heterocyclic oxidation dye leads to a clearly less potent coloration than the dye composition. ready for the use of Example 2 according to the invention and containing at least one heterocyclic compound, namely a heterocyclic oxidation base which is 2, 4, 5, 6-tetra-aminopyrimidine.
COMPARATIVE EXAMPLES 3 AND 4 The following ready-to-use dye compositions were prepared (contained in grams):
(*) Example that does not form part of the invention (***): Common dyeing support: - Ethanol - - 20.0 g - Hydroxypropylated guar gum sold under the name JAGUAR HP 60 by the MAYRALL company - 1.6 g
- Alkyl (Cs-Cio) polyglucoside in 60% aqueous solution of active material (M.A.) buffered by ammonium citrate (0.5%), sold under the name ORAMIX CG110 by the company S 8.0 g
- Monoethanolamine c.s. pH 9.5 It is important to appreciate that each of the ready-to-use dye compositions described above contains the same amount of each of the oxidation bases, namely 6.10-3 moles. At the time of use, each of the ready-to-use dye compositions described above was mixed with an equal amount by weight of a 20 volume hydrogen peroxide solution.
(6% by weight). Each of the resulting mixtures was applied on wicks of natural gray hair to 90% of whites for 30 minutes. The hair strands were then rinsed, washed with an ordinary shampoo, rinsed again and then dried. As described above for the examples 1 and 2 indicated above, the coloration was evaluated by the MUNSELL system, before and after the dyeing, by means of a CM2002 MINOLTA colorimeter. The strength of the coloring was calculated applying the NICKERSON formula. The results are indicated in Table II given below:
Table II
(*): Example that is not part of the invention. Contrary to what has been demonstrated above for comparative examples 1 and 2, these results show that using a classical oxidant system that does not form part of the invention, "as for example here hydrogen peroxide, the substitution of a benzene dye by a heterocyclic dye (here the paraphenylenediamine was substituted by 2, 4, 5, 6-tetra-aminopirimidina), does not allow to increase the strength of the obtained placements.
EXAMPLES 5 AND 6 COMPARATIVE
The following ready-to-use dye compositions were prepared (contained in grams)
(*) Example that does not form part of the invention (**): Common dyeing support: It is identical to that used for examples 1 and 2 indicated above. It is important to appreciate that each of the ready-to-use dye compositions described above contains the same molar amount of each of the oxidation bases, namely 3.10"3 moles Each of the ready-to-use dye compositions described above is applied on natural gray hair to 90% whites for 30 minutes The hair was then rinsed, washed with a normal shampoo, then dried, as described above for examples 1 and 2 indicated above, coloring It was evaluated by the MUNSELL system, before and after the dye, by means of a CM2002 MINOLTA colorimeter The strength of the coloration was calculated applying the NICKERSON formula The results are indicated in the following table III.
(*): Example that is not part of the invention. These results show that in the presence of the Uricase / Uric Acid oxidizing system, the ready-to-use dye composition for example 5, which does not form part of the invention, since it contains 2,5-diaminopyridine, which is a base of monocyclic pyridine oxidation, excluded from the invention leads to a clearly less strong coloration than the ready-to-use dye composition for the use of example 6 according to the invention and containing at least one heterocyclic compound according to the invention, namely a base of heterocyclic oxidation which is 2.4 , 5,6-tetraaminopyrimidine. EXAMPLES 7 TO 13 OF DYING The ready-to-use dye compositions according to the invention were prepared as follows (contents in grams):
t o o
> Os ** Support e tten com n
It is identical to the one used for the examples 1 and 2 indicated above. Each of the ready-to-use dye compositions described above was applied on gray hair strands to 90% white, natural or permed, for 30 minutes. The hair was then rinsed, washed with an ordinary shampoo, and then dried. The hair strands were stained in the shades listed in Table IV given below.
Table IV
It is noted that in relation to this date, the best method known by the applicant, to implement the aforementioned invention, is that which is clear from the manufacture of the objects to which it refers.
Having described the invention as above it is claimed as "property contained in the following.
Claims (37)
1. Ready-to-use composition for the oxidation dyeing of keratin fibers and in particular of human keratin fibers such as hair, which "comprises the combination of at least one oxidation base and at least one copulator, characterized by the The fact that it comprises, in a medium suitable for dyeing, at least one 2-electron oxide-reductase-type enzyme in the presence of at least one donor for said enzyme, and because said oxidation base and / or said copulator is chosen from the heterocyclic compounds excluding the monocyclic pyridine compounds 2.
Composition according to claim 1, characterized in that the oxidoreductase with 2 electrons is chosen among uricases of animal, microbiological or biotechnological origin.
Claim 1 or 2, characterized in that the 2-electron oxido-reductases represent from 0.01 to 20% in pe of the total weight of the dye composition ready for use.
Composition according to claim 3, characterized in that the 2-electron oxide or reductases represent from 0.1 to 5% by weight of the total weight of the ready-to-use dye composition.
5. Composition according to claim 2, characterized in that the donor (or substrate) for the indicated 2-electron oxido-reductase is chosen from uric acid and its salts.
Composition according to any one of the preceding claims, characterized in that the donor (s) represent from 0.01 to 20% by weight of the total weight of the dye composition ready for use.
Composition according to Claim 6, characterized in that the donor (s) represent from 0.1 to 5% by weight of the total weight of the dye composition ready for use.
8. Composition according to any one of the preceding claims, characterized in that the heterocyclic oxidation base (s) are chosen from the pyrimidine derivatives, the pyrazole derivatives and their addition salts with an acid.
9. The composition according to claim 8, characterized in that the pyrimidine derivatives are selected from 2, 4, 5, 6-tetra-aminopyrimidine, 4-hydroxy-2, 5, 6-triaminopyrimidine, pyrazole pyrimidine derivatives, and its addition salts with an acid.
Composition according to Claim 9, characterized in that the pyrazole pyrimidine derivatives are chosen from pyrazolo [1,5-a] -pyrimidine-3,7-diamine, 2-methyl pyrazolo- [1,5-a] ] -pyrimidine-3,7-diamine, 2,5-dimethylpyrazolo- [1,5-a] -pyrimidine-3,7-diamine, pyrazolo [1,5-a] -pyrimidine-3, 5- diamine, 2,7-dimethylpyrazolo [1,5-a] -pyrimidine-3,5-diamine, 3-amino pyrazolo- [1,5-a] pyrimidin-7-ol, 3-amino-5- methyl pyrazolo- [1, 5-a] -pyrimidin-7-ol, 3-amino pyrazolo- [1, 5-a] -? irimidin-5-ol, 2 (3-amino pyrazolo- [1, 5] -a] -pyrimidin-7-ylamino) -ethanol, 3-amino-7-β-hydroxyethylamino-5-methyl-pyrazolo- [1,5-a] -pyrimidine, 2- (7-amino pyrazolo- [ 1,5-a] -pyrimidin-3-ylamino) -ethanol, 2- [(3-amino-pyrazolo- [1, 5-a] pyrimidin-7-yl) - (2-hydroxyethyl) -amino] - ethanol, 2- [(7-amino-pyrazolo- [1,5-a] pyrimidin-3-yl) - (2-hydroxyethyl) -amino] -ethanol, 5,6-dimethylpyrazolo- [1,5 -a] -p? rimidma-3, 7-diamine, the 2,6-dime Useful pyrazolo- [1, 5-a] -pyrimidine-3,7-diamine, 2,5, N-7-tetramethyl pyrazolo- [1, 5-a] -pyrimidine-3,7-diamine, and its salts of addition and its tautomeric forms, when there is a tautomeric equilibrium.
The composition according to claim 8, characterized in that the pyrazole derivatives are chosen from 4,5-diamino pyrazole, 4,5-diamino-1-methyl pyrazole, 1-benzyl 4,5-diamino pyrazole, 3,4-diamino pyrazole, 1-benzyl 4,5-diamino-3-methyl pyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 4,5-diamino-3-methyl-1-phenyl-pyrazole, 4,5-diamino-3-methyl-1-tert-butyl pyrazole, 4,5-diamino-1-methyl-3-tert-butyl pyrazole, 4,5-diamino-1-ethyl-3-methyl-pyrazole, 4, 5-diamino-ethyl-3- (4'-methoxyphenyl) pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethyl pyrazole, 4,5-diamino-3-hydroxymethyl-1-methyl-pyrazole, 4,5- diamino 3-hydroxymethyl-1-isopropyl pyrazole, 4,5-diamino-3-methyl-1-isopropyl pyrazole, and their addition salts with an acid.
Composition according to any one of the preceding claims, characterized in that the heterocyclic oxidation base (s) represent from 0.0005 to 12% by weight of the total weight of the ready-to-use dye composition.
13. Composition according to claim 12, characterized in that the heterocyclic oxidation base (s) represent from 0.005 to 6% by weight of the total weight of the ready-to-use dye composition.
Composition according to any one of the preceding claims, characterized in that he or the heterocyclic couplers are chosen from the indole derivatives, the indoline derivatives, the benzimidazole derivatives, the benzomorpholine derivatives, the sesamol derivatives, the pyrazole-azole derivatives, pyrrolo-azole derivatives, imidazole-azole derivatives, pyrazolo-pyrimidine derivatives, pyrazolin-3, 5-diones derivatives, pyrrolo- [3, 2-d] -oxazole derivatives, derivatives pyrazolo- [3, -d] -thiazoles, the thiozole-azole S-oxide derivatives, the S, S-dioxide-thiazole-azole derivatives, and their addition salts with an acid.
15. Composition according to claim 14, characterized in that the indole derivatives are chosen from the following compounds of formula (I), and their addition salts with an acid: wherein: R1 represents a hydrogen atom, an alkyl radical of Ct.-C4, a mono- or polyhydroxyalkyl radical of C2-C4 or ammoalkyl of C? -C4 whose amine is mono or disubstituted by an alkyl group of C? -C4; R2 represents a hydrogen atom or an alkyl radical of C? _C; R3 represents a hydrogen atom, a C1-C4 alkyl radical or hydroxyl; X represents a hydroxyl radical or NHR4 in which R4 represents a hydrogen atom, an alkyl radical of Ci-C4 or hydroxyalkyl of C1-C4.
16. - The composition according to claim 15, characterized in that the indole derivatives are chosen from 4-hydroxy indole, 6-hydroxy indole, 7-amino indole, 6-amino indole, 7-hydroxy indole , 7-ethyl 6- (β-hydroxyethyl) amino indole, 4-amino indole, 6-hydroxy 1-methyl indole, 5,6-dihydroxy indole, 4-hydroxy 1-N-methyl indole, 4-hydroxy 2-methyl indole, 4-hydroxy 5-methyl indole, 4-hydroxy-lN- (β-hydroxyethyl) indole, 4-hydroxy 1-N- (β-hydroxypropyl) indole, 1-N- (β, α-dihydroxypropyl) 4-hydroxy indole, 4-hydroxy 1-N- (β-hydroxyethyl) 5-methyl indole, 1-N- (β-dimethylaminopropyl) 4-hydroxy indole, and their addition salts with an acid.
17. The composition according to claim 14, characterized in that the indoline derivatives are chosen from 4-hydroxy indoline, 6-hydroxy indoline, 6-amino indoline, 5,6-dihydroxy indoline, and their salts. addition with an acid.
18. Composition according to claim 14, characterized in that the benzimidazole derivatives are chosen from the following compounds of formula (II), and their addition salts with an acid wherein: R5 represents a hydrogen atom or an alkyl radical of C? -C4, Rg represents a hydrogen atom, a radical "C? -C4 alkyl or phenyl, R7 represents a hydroxyl, amino or methoxy radical, R8- represents a hydrogen atom, a hydroxy, methoxy or alkyl radical of C? -C4, with the proviso that: - when R7 designates an amino radical, then it occupies position 4, when R7 _ occupies position 4, then R8 occupies position 7, when R occupies position 5, then R8 occupies position. position 6
19. Composition according to claim 18, characterized in that the benzimidazole derivatives are chosen 4-hydroxybenzimidazole, 4-aminobenzimidazole, 4-hydroxy-7-methylbenzimidazole, 4-hydroxy-2-methylbenzimidazole, -butyl 4-hydroxybenzimidazole, 4-amino-2-methyl-benzimidazole, 5,6-dihydroxy-benzimidazole, 5-hydroxy-6-methoxy-benzimidazole, 4,7-dihydroxy-benzimidazole, 4,7-dihydroxy-1-methyl benzimidazole, 4,7-dimethoxy benzimidazole, 5,6-dihydroxy 1-methyl benzimidazole, 5,6-dihydroxy 2-methyl benzimidazole, 5,6-dimethoxy benzimidazole, and their addition salts with an acid.
The composition according to claim 14, characterized in that the benzomorpholine derivatives are chosen from the following compounds of formula (III), and their addition salts with an acid: in which R_ and Rio, identical or different, represent a hydrogen atom or a C 1 -C 4 alkyl radical, Z represents a hydroxyl or amino radical.
21. The composition according to claim 20, characterized in that the benzomorpholine derivatives are chosen from 6-hydroxy-1,4-benzomorpholine, N-methyl-6-hydroxy-1,4-benzomorpholine, 6-amino-1 , 4-benzomorpholine, and its addition salts with an acid.
22. The composition according to claim 14, characterized in that the sesamol derivatives are chosen from the following compounds of formula (IV), and their addition salts with an acid: wherein: R n denotes a hydroxyl radical, amino alkyl '(C? -C4) amino, monohydroxyalkyl (C? ~ C4) amino or polyhydroxyalkyl (C2-C4) amino, R12 designates a hydrogen or halogen atom or a C? -C4 alkoxy radical
23. Composition according to claim 22, characterized in that the sesamol derivatives are chosen from 2-bromo 4, 5-methylenedioxy phenol, 2-methoxy 4,5-methylenedioxy aniline, 2- (β-hydroxyethyl) amino 4,5-methylenedioxy benzene, and their addition salts with an acid.
24. Composition according to claim 14, characterized in that the pyrazolo-azolic derivatives are chosen from: - 2-methyl pyrazolo [1,5-b] -1,2,4-triazole, - 2- ethyl pyrazolo [1,5-b] -1,2,4-triazole, - 2-isopropyl pyrazolo [1,5-b] -1,2,4-triazole, - 2-phenyl pyrazolo [1,5 -b] -1, 2, 4-triazole, - 2,6-dimethylpyrazolo [1,5-b] -1,2,4-triazole, - 7-chloro-2,6-dimethylpyrazolo [1, 5-b] -1, 2, 4-triazole, - 3,6-dimethyl-pyrazolo [3,2-c] -1,2,4-triazole - 6-phenyl-3-methylthio-pyrazolo [3, 2-c] -1, 2, 4- triazole, 6-Amino-pyrazolo [1, 5-a] benzimidazole, and its addition salts with an acid.
25. The composition according to claim 14, characterized in that the pyrrolozole derivatives are chosen from: - 5-cyano-4-ethoxycarbonyl-8-methyl pyrrolo [1,2-b] -1, 2, 4 -triazole, - 5-cyano-8-methyl-4-phenyl pyrrolo [1,2-b] -1, 2,4-triazole, 7-amido-6-ethoxycarbonyl pyrrolo [1,2-a] -benzimidazole and its addition salts with an acid. TO
26. Composition according to claim 14, characterized in that the imidazole-azolic derivatives are chosen from: - 7, 8-dicyano-imidazole- [3, 2-a] -imidazole, - 7, 8-dicyano-4 -methyl-imidazole- [3, 2-a] -imidazole, and its addition salts with an acid.
Composition according to claim 14, characterized in that the pyrazolopyrimidine derivatives are chosen from: - pyrazolo [1,5-pyrimidin-7-one, - 2,5-dimethylpyrazolo [1,5-a] ] pyrimidin-7-one, 2-methyl-6-ethoxycarbonyl pyrazolo [1,5-a] pyrimidin-7-one, - 2-methyl-5-methoxymethyl pyrazolo [1,5-a] pyrimidine-7 ona, - 2-tert-butyl-5-trifluoromethyl-pyrazolo [1, 5-a] pyrimidin-7-one, - 2,7-dimethyl pyrazolo [1, 5-a] pyrimidin-5-one, and its salts of addition with an acid.
Composition according to Claim 14, characterized in that the pyrazolin-3, 5-diones derivatives are chosen from: - 1,2-diphenylpyrazolin-3,5-dione, - 1,2-diethylpyrazolin-3, 5-dione, and its salts and addition with an acid.
29. Composition according to any one of the preceding claims, characterized in that the heterocyclic coupler (s) represent from 0.0001 to 10% by weight of the total weight of the ready-to-use dye composition.
30. Composition according to claim 29, characterized in that the heterocyclic coupler (s) represent from 0.005 to 5% by weight of the total weight of the dye composition ready for use.
31. Composition according to any one of the preceding claims, characterized in that it contains at least one additional oxidation base selected from paraphenylenediamines, bis-phenylalkylenediamines, orthophenylenediamines, "para-aminophenols, ortho-aminophenols, and their addition salts. with an acid and / or at least one additional coupler selected from eta-phenylenediamines, meta-aminophenols, meta-diphenols, and their addition salts with an acid
32. Composition according to any one of the preceding claims, characterized by The fact that the addition salts with an acid are chosen from hydrochlorides, hydrobromides, sulfates and tartrates, lactates and acetates.
33. Composition according to any one of the preceding claims, characterized in that the means suitable for dyeing is constituted by water or by a mixture of water and by at least one organic solvent.
Composition according to any one of the preceding claims, characterized in that it has a pH comprised between 5 and 11.
35. Composition according to any one of the preceding claims, characterized in that it contains at least one peroxidase. .
36. Method of dyeing keratin fibers _ and in particular human keratin fibers such as hair, characterized in that at least one ready-to-use dye composition as defined in any one of the above-mentioned fibers is applied to said fibers. previous claims, for a sufficient time to develop the desired coloration.
37. The method according to claim 36, characterized in that it comprises a preliminary step consisting of storing separately, on the one hand, a composition (A) comprising, in a medium suitable for dyeing, at least one base of heterocyclic oxidation as defined in any one of claims 1, 8 to 13 and 32 and / or at least one heterocyclic coupler as defined in any one of claims 1, 14 to 30 and 32, and, on the other hand, a composition (B) that includes, in a medium suitable for dyeing, at least one 2-electron oxido-reductase-type enzyme in the presence of at least one donor for the indicated enzyme, then in proceeding to its mixing at the time of use before applying this mixture on the keratin fibers.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR97/06802 | 1997-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99010758A true MXPA99010758A (en) | 2000-09-04 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0994692B1 (en) | Oxidation dyeing composition for keratinous fibres containing a 3-aminopyridine azo derivative and dyeing method using said composition | |
US7594936B2 (en) | Dye composition for keratin fibers containing an aldehyde precursor, enzyme and hydrazone, and method using this composition | |
EP0930062A1 (en) | Compositions containing imidazo-pyridine derivatives for dying keratinous fibres and process | |
CA2289723A1 (en) | Oxidation dyeing compound for keratin fibres and dyeing procedure involving this compound | |
FR2791563A1 (en) | KERATIN FIBER OXIDATION DYEING COMPOSITION AND DYEING METHOD USING THE SAME | |
EP1057471A1 (en) | Composition for oxidative dying of keratinous fibres and dying process therewith | |
EP1413286B1 (en) | Dyeing composition comprising at least one heterocyclic oxidation base and at least one substituted 2,3-diaminopyridine as a coupling agent | |
ES2205548T3 (en) | COMPOSITION OF DYEING BY OXIDATION OF KERATIN FIBERS AND DYING PROCEDURE USING THIS COMPOSITION. | |
ES2212299T3 (en) | COMPOSITION OF DYEING BY OXIDATION OF KERATIN FIBERS AND DYING PROCEDURE USING THIS COMPOSITION. | |
WO2003028686A1 (en) | Dyeing composition comprising a diaminopyrazole-type oxidation base and a pyrazolo-azole coupling agent | |
EP1352636B1 (en) | Oxidation dyeing composition for keratin fibers comprising 2-chloro-6-methyl-3-aminophenol and an oxidation base, and dyeing method | |
FR2831055A1 (en) | Oxidation dye composition, useful for dyeing keratinic fibers, comprises 1-(2-hydroxyethyl)-4-hydroxyindole as a coupler and a heterocyclic developer | |
RU2000100367A (en) | COMPOSITION FOR OXIDATIVE PAINTING OF KERATIN FIBERS AND COLOR METHOD IN WHICH USE THIS COMPOSITION | |
KR100364310B1 (en) | DYEING COMPOSITION CONTAINING A PYRAZOLO-[1,5-a]-PYRIMIDINE AS OXIDATION BASE AND A PYRIDINE COUPLING AGENT, AND DYEING METHOD | |
EP1405628A1 (en) | Dyeing composition comprising at least one pyrazolopyrimidine oxidation base and at least one 6-alkoxy-2,3-diaminopyrimidine coupler | |
FR2773481A1 (en) | Composition for oxidation dyeing of keratinic fibers, especially human hair | |
MXPA99010758A (en) | Keratin fibre oxidation dyeing composition and dyeing method using same | |
EP1586302A1 (en) | Dye composition comprising at least one pyrazolopyrimidine as oxidation base and at least one 6-alkoxy-2,3-diaminopyridine as coupler | |
EP1093788A1 (en) | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | |
EP1093793A2 (en) | Composition for oxidative dyeing of keratinous fibres and dyeing process using same | |
CZ426799A3 (en) | Preparation for oxidative dyeing keratin fibers and dyeing process employing such preparation | |
CZ207499A3 (en) | Dyeing mixture for oxidative dyeing keratin fibers and method of using thereof | |
FR2845282A1 (en) | Composition useful for dyeing keratinic fibers, e.g. hair, comprises a 2,3-diaminopyridine coupler and a non-fused pyrazole developer | |
MXPA99004998A (en) | Oxidation dyeing composition for keratin fibres and dyeing method using said composition | |
MXPA00001637A (en) | Composition for oxidative dyeing of keratinous fibres and dyeing process using same |